(ONPH - ONCOLOGY PHARMA INC)

company profile

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Oncology Pharma (ONPH) is trading at 0.0055

Open Price
0.0045
Previous close
0.0055
Previous close
0.0055
P/E Ratio
0
Sector
Health Care
Shares outstanding
38563216
Primary exchange
OTC Markets
ISIN
US68235J2015